Most grade II and grade III gliomas, as well as the secondary glioblastomas that arise from these tumors, possess point mutations that affect the substrate binding site of isocitrate dehydrogenase.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback